Processa Pharmaceuticals, Inc. Due from Related Parties, Current
Processa Pharmaceuticals, Inc. (PCSA) had Due from Related Parties, Current of $3.57 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes
us-gaap:DueFromRelatedPartiesCurrent · last filed 2022-03-30
- 2021-03-31: Due from Related Parties, Current $3.57K.
- 2020-12-31: Due from Related Parties, Current $154.73K.
- 2020-09-30: Due from Related Parties, Current $7.61K.
- 2020-06-30: Due from Related Parties, Current $26.50K.
| Period end | Due from Related Parties, Current |
|---|---|
| 2021-03-31 | $3.57K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $154.73K 10-K · filed 2022-03-30 |
| 2020-09-30 | $7.61K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $26.50K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $28.00K 10-Q · filed 2020-05-15 |
| 2019-09-30 | $663.00 10-Q · filed 2019-11-14 |
| 2019-03-31 | $47.16K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $21.58K 10-K · filed 2020-03-06 |
| 2018-09-30 | $94.77K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $56.51K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $26.68K 10-Q · filed 2018-05-21 |
| 2017-12-31 | $62.71K 10-K/A · filed 2019-04-08 |
| 2017-03-31 | $29.43K 10-Q · filed 2018-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |